253 related articles for article (PubMed ID: 22204001)
21. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
[TBL] [Abstract][Full Text] [Related]
22. Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns.
Caiafa P; Guastafierro T; Zampieri M
FASEB J; 2009 Mar; 23(3):672-8. PubMed ID: 19001527
[TBL] [Abstract][Full Text] [Related]
23. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells.
Ojo OO; Ryu MH; Jha A; Unruh H; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1354-66. PubMed ID: 26432865
[TBL] [Abstract][Full Text] [Related]
24. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.
Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE
Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribosyl)ation of Methyl CpG Binding Domain Protein 2 Regulates Chromatin Structure.
Becker A; Zhang P; Allmann L; Meilinger D; Bertulat B; Eck D; Hofstaetter M; Bartolomei G; Hottiger MO; Schreiber V; Leonhardt H; Cardoso MC
J Biol Chem; 2016 Mar; 291(10):4873-81. PubMed ID: 26772194
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation.
Tancharoen S; Tengrungsun T; Suddhasthira T; Kikuchi K; Vechvongvan N; Tokuda M; Maruyama I
Mediators Inflamm; 2014; 2014():754069. PubMed ID: 25114379
[TBL] [Abstract][Full Text] [Related]
27. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.
Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A
Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633
[TBL] [Abstract][Full Text] [Related]
28. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
[TBL] [Abstract][Full Text] [Related]
29. Extracellular HMGB1 Impairs Macrophage-Mediated Efferocytosis by Suppressing the Rab43-Controlled Cell Surface Transport of CD91.
Wang Y; Zhang W; Xu Y; Wu D; Gao Z; Zhou J; Qian H; He B; Wang G
Front Immunol; 2022; 13():767630. PubMed ID: 35392093
[TBL] [Abstract][Full Text] [Related]
30. Luteolin attenuates hepatic injury in septic mice by regulating P2X7R-based HMGB1 release.
Zhang ZH; Yang HX; Jin Q; Wu YL; Cui ZY; Shang Y; Liu J; Zhan ZY; Lian LH; Nan JX
Food Funct; 2021 Nov; 12(21):10714-10727. PubMed ID: 34607339
[TBL] [Abstract][Full Text] [Related]
31. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
[TBL] [Abstract][Full Text] [Related]
32. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
33. From the Cover: Tetrachlorobenzoquinone Exerts Neurological Proinflammatory Activity by Promoting HMGB1 Release, Which Induces TLR4 Clustering within the Lipid Raft.
Fu J; Shi Q; Song X; Liu Z; Wang Y; Wang Y; Song E; Song Y
Toxicol Sci; 2016 Oct; 153(2):303-15. PubMed ID: 27413111
[TBL] [Abstract][Full Text] [Related]
34. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.
Achouiti A; van der Meer AJ; Florquin S; Yang H; Tracey KJ; van 't Veer C; de Vos AF; van der Poll T
Crit Care; 2013 Dec; 17(6):R296. PubMed ID: 24342460
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-κB transcription in murine macrophages.
Liu L; Ke Y; Jiang X; He F; Pan L; Xu L; Zeng X; Ba X
Hum Immunol; 2012 May; 73(5):439-47. PubMed ID: 22391342
[TBL] [Abstract][Full Text] [Related]
36. HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts.
Masaoka A; Gassman NR; Kedar PS; Prasad R; Hou EW; Horton JK; Bustin M; Wilson SH
J Biol Chem; 2012 Aug; 287(33):27648-58. PubMed ID: 22736760
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
[TBL] [Abstract][Full Text] [Related]
38. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation.
Mendoza-Alvarez H; Alvarez-Gonzalez R
J Biol Chem; 2001 Sep; 276(39):36425-30. PubMed ID: 11477085
[TBL] [Abstract][Full Text] [Related]
39. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
40. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
